|
Volumn 25, Issue 1, 2006, Pages 80-84
|
Treatment and prognosis of stage III-IV laryngeal squamous cell carcinoma
a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BLEOMYCIN;
CISPLATIN;
FLUOROURACIL;
ADULT;
AGED;
ARTICLE;
CANCER STAGING;
COMPARATIVE STUDY;
FEMALE;
FOLLOW UP;
HUMAN;
LARYNGECTOMY;
LARYNX TUMOR;
MALE;
METHODOLOGY;
MIDDLE AGED;
MULTIMODALITY CANCER THERAPY;
PROGNOSIS;
RETROSPECTIVE STUDY;
SQUAMOUS CELL CARCINOMA;
SURVIVAL RATE;
TREATMENT OUTCOME;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BLEOMYCIN;
CARCINOMA, SQUAMOUS CELL;
CISPLATIN;
COMBINED MODALITY THERAPY;
FEMALE;
FLUOROURACIL;
FOLLOW-UP STUDIES;
HUMANS;
LARYNGEAL NEOPLASMS;
LARYNGECTOMY;
MALE;
MIDDLE AGED;
NEOPLASM STAGING;
PROGNOSIS;
RETROSPECTIVE STUDIES;
SURVIVAL RATE;
TREATMENT OUTCOME;
|
EID: 33747844662
PISSN: 1000467X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (6)
|
References (0)
|